SurpassMD Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: shoppers who want one price at every dose and can commit to a longer supply term
SurpassMD scores highest on state availability and ease of access.
Semaglutide
then $219/mo ongoing
Tirzepatide
then $309/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
SurpassMD is an online GLP-1 weight loss platform from Life Vitality LLC that connects patients with independent licensed providers for compounded semaglutide, tirzepatide and oral semaglutide, dispensed by licensed compounding pharmacies. Month-to-month plans cost $219/mo for semaglutide and $309/mo for tirzepatide at every dose, with lower rates on 3-, 6- and 12-month supplies and a first-subscription discount code. It is cash-pay only, with HSA/FSA and Klarna accepted.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to SurpassMD
Ro
Best for: FDA-approved brand GLP-1s, including the Wegovy pill and Foundayo, with insurance help
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
CoreAge Rx
Best for: lowest-price compounded semaglutide and tirzepatide with one flat price at every dose
Editorial score · methodology
SurpassMD at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide, Oral Semaglutide
- Starting price
- $219/mo (after intro offer) ($175 first subscription)
- Pricing model
- Flat: dose increases don't raise the monthly price
- What's included
- Consult · Medication · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored SurpassMD
Each dimension is scored algorithmically from SurpassMD’s published pricing, drugs offered, verification status, and disclosed inclusions, using the same six-dimension framework we apply to every provider.
Value25%
6.7/10At $219/mo (after intro offer), SurpassMD runs about 20% above the $182 median for GLP-1 providers (each program's lowest listed ongoing monthly price for compounded semaglutide), with an intro price of $175. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.7/10SurpassMD offers both semaglutide and tirzepatide, the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
6.9/10Online intake and platform experience (consult included in the price); 8 platform features disclosed.
Trust & Safety15%
7.6/10Key details fully confirmed by our editors; no FDA warning letters on file.
Accessibility10%
8.2/10SurpassMD treats patients in all 50 states plus DC. FSA/HSA cards are accepted.
Support10%
5.4/10SurpassMD provides standard clinician follow-up; no extended coaching or community program is disclosed.
Each checked against the provider’s own site.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this SurpassMD review
Last checked October 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed availability in all 50 states plus DC
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records. See the sources below. Editorial confidence in this data: high.
What we checked
- Provider's own pricing page
- $219–$309/mo across 2 dose/plan tiers (checked October 2026)
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with SurpassMD
We walked SurpassMD’s public signup flow in August 2026 to document the process (the steps, pricing transparency, and what’s required) before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Landing step: 'Start my free assessment' (no payment required)
- 2Enter height (feet/inches) and weight (lbs); app auto-calculates BMI
- 3Select a weight-loss goal (e.g., 'Lose 21-50 lbs for good')
- 4Select reasons for wanting to change (life expectancy, appearance, health risks, mental health)
- 5View a personalized 3-month weight-projection chart, explicitly disclaimed as an estimate based on other patients, not a guarantee
- 6Enter email and check a mandatory box agreeing to OpenLoop's Telehealth Consent, Terms of Use, and Notice of Privacy Practices
- Month-to-month prices ($219/mo semaglutide, $309/mo tirzepatide, with lower 3-, 6- and 12-month rates) are published on the site before you start the quiz, but the quiz's opening screens never display a price.
- The funnel's required consent step names OpenLoop as the party behind the Telehealth Consent, Terms of Use, and Notice of Privacy Practices you must accept. SurpassMD's own marketing pages and Terms of Use never name OpenLoop; they refer only to an unnamed 'independent professional medical corporation.'
- The marketing-email opt-in checkbox is unchecked by default and optional; the OpenLoop telehealth consent checkbox is mandatory to proceed.
- The health-history questionnaire and the plan-selection and checkout screens sit behind a reCAPTCHA on the email step, so the per-dose price ladder and exact billing cadence (monthly vs. every-4-weeks) can't be confirmed beyond the Terms of Use's generic billing-cycle language.
- Per the separate Refund Policy page, billing begins as soon as the intake form is submitted (before the licensed provider reviews or approves treatment), though a full refund is promised if you are disqualified.
SurpassMD customer support
- Phone
- 1-502-515-4576
- care@surpassmd.com
- Hours
- Monday-Friday, 9 AM-6 PM PT
GLP-1 medications SurpassMD offers
Tap any medication to read our plain-English guide: how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
$175 first subscription with a SurpassMD discount code, then $219/mo. Longer plans: 3-mo $195/mo, 6-mo $180/mo, 12-mo $143/mo (intro $156, $144, $114).
$247 first subscription with a SurpassMD discount code, then $309/mo. Longer plans: 3-mo $299/mo, 6-mo $275/mo, 12-mo $222/mo (intro $232, $220, $177).
Ready to get started?
Plans and promotions change often, so check SurpassMD's current pricing and active discounts before you decide.
What we like
- Publishes a full price table by supply term: $219/mo semaglutide and $309/mo tirzepatide month-to-month
- Same price at every dose, with provider review, medication and shipping included and no membership fee
- Broad coverage: offers services in all 50 states plus DC
- HSA/FSA and Klarna buy-now-pay-later accepted
- Full refund if the medical provider disqualifies you
- Also offers an oral semaglutide tablet plan for people who prefer to avoid injections
Watch-outs
- The $114 and $177 'as low as' prices need a 12-month supply plus a discount code; month-to-month costs $219 and $309
- Specific compounding pharmacy partner is not named on the site
- LegitScript Certified badge shown, but no verifiable LegitScript record found
- Cancellation & Refund Policy page conflicts with the Terms of Use on refund eligibility
- Billing begins at intake submission, before provider approval
- Refund policy requires 72 hours' notice before your next billing date to cancel
- Oral semaglutide shows only a first-month price of $183; the ongoing rate is not published
Is SurpassMD worth it?
SurpassMD is aimed squarely at shoppers who want one price at every dose and can commit to a longer supply term. New patients start at $175/month for the first subscription, but the price steps up to $219/month once that window ends, so treat the headline number as an intro offer, not the standing rate. Its standout is a needle-free oral option for people who would rather not inject.
It ships cold-chain. It also takes HSA/FSA payment and offers payment plans.
How much SurpassMD costs
- Compounded semaglutide starts at $175 for the first subscription, then $219/month after that, if you go that route.
- Compounded tirzepatide starts at $247 for the first subscription, then $309/month after that, at that tier.
Because SurpassMD's headline figure is listed as “after intro offer”, we don't set it against the roughly $182 market median for this category. That median is each program's lowest listed ongoing monthly price for compounded semaglutide, so compare SurpassMD with the month-to-month prices of the alternatives below instead.
For a direct comparison, Belle Health runs semaglutide and tirzepatide from $199/month, so compare it with SurpassMD before you commit.
Medications: what SurpassMD prescribes
SurpassMD prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro), the two molecules with the strongest published weight-loss trial outcomes. The medication is compounded at a licensed pharmacy rather than sold as a brand pen, which is what keeps the price down. The trade-off is the one every compounded provider shares: compounded drugs aren't FDA-approved as finished products.
SurpassMD's needle-free oral option appeals if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral, sublingual and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who SurpassMD is best for, and who should skip it
A good fit if you…
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
- live anywhere in the US and want the certainty that your state is already covered.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation, which this provider doesn't fill.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
SurpassMD treats patients in all 50 states, and we found no FDA warning letter on file for it. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation, and we explain how in our scoring methodology.
Bottom line
SurpassMD's intro price of $175 takes some of the cost out of the first subscription, but plan around the $219/month standing price, since that is what you pay from then on.
The Bottom Line
SurpassMD scores highest on state availability and ease of access.
Ready to start with SurpassMD?
From $219/mo (after intro offer). See current pricing and start your free consultation.
SurpassMD might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
Head-to-head
Compare SurpassMD vs…
SurpassMD scores7.1/10
Side-by-side pricing, medications and scores. Pick a matchup.
SurpassMD vs Amazon One Medical
Amazon One Medical scores 8.5/10

SurpassMD vs Vytora Health
Vytora Health scores 8.4/10
Scores are our independent editorial ratings out of 10.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this SurpassMD review:
Sources & methodology (as of November 2026)
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See SurpassMD's current pricing
Plans from $219/mo (after intro offer). Start your free consultation to check eligibility and today's price.